SPNE NASDAQ

SeaSpine Holdings Corporation is a medical technology firm specializing in the creation, development, and global marketing of advanced surgical solutions for treating spinal disorders. The company offers an extensive portfolio of orthobiologics and spinal implant systems, which are primarily utilized by neurosurgeons and orthopedic spine specialists to perform spinal fusion procedures in the cervical, thoracic, and lumbar regions. Their orthobiologic product line features various bone graft substitutes, including demineralized bone matrix (DBM), collagen ceramic matrices, demineralized cancellous allografts, and synthetic bone void fillers. These materials are engineered to improve bone fusion rates in a wide array of orthopedic operations, extending beyond the spine to include hip and extremity procedures. These orthobiologics are available in diverse forms such as fibers, putties, pastes, strips, and DBM. Furthermore, SeaSpine provides implantable devices designed for spinal decompression, alignment correction, and stabilization. Complementing these, the company offers sophisticated image-guided surgical solutions, including a dedicated surgical navigation system. This system is instrumental in facilitating fusion during complex procedures for degenerative conditions, minimally invasive interventions, and severe spinal deformities across the entire spinal column. Established in 2015, SeaSpine Holdings Corporation is headquartered in Carlsbad, California.